Financial reports
10-Q
2023 Q2
Quarterly report
14 Feb 24
10-Q
2024 Q1
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
31 Jul 23
10-Q
2023 Q1
Quarterly report
17 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Regulation FD Disclosure
10 Apr 24
8-K
Other Events
8 Mar 24
8-K
Entry into a Material Definitive Agreement
6 Mar 24
8-K
Changes in Registrant's Certifying Accountant
2 Feb 24
8-K
Estrella Immunopharma Announces $1 Million Share Repurchase Authorization
30 Jan 24
8-K/A
Amendments to Articles of Incorporation or Bylaws
14 Nov 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Entry into a Material Definitive Agreement
20 Sep 23
8-K
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
18 Sep 23
8-K
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
18 Aug 23
Registration and prospectus
424B3
Prospectus supplement
8 Mar 24
424B3
Prospectus supplement
7 Mar 24
424B3
Prospectus supplement
15 Feb 24
424B3
Prospectus supplement
12 Feb 24
424B3
Prospectus supplement
28 Dec 23
S-1/A
IPO registration (amended)
15 Dec 23
S-1/A
IPO registration (amended)
13 Nov 23
S-1
IPO registration
10 Oct 23
25-NSE
Exchange delisting
5 Oct 23
425
Business combination disclosure
20 Sep 23
Proxies
DEFA14A
Additional proxy soliciting materials
26 Jul 23
DEFA14A
Additional proxy soliciting materials
12 Jul 23
DEF 14A
Definitive proxy
16 Jun 23
PRER14A
Preliminary revised proxy
2 Jun 23
PRE 14A
Preliminary proxy
25 May 23
DEF 14A
Definitive proxy
6 Dec 22
PRER14A
Preliminary revised proxy
2 Dec 22
PRE 14A
Preliminary proxy
25 Nov 22
Other
EFFECT
Notice of effectiveness
29 Dec 23
CORRESP
Correspondence with SEC
27 Dec 23
CORRESP
Correspondence with SEC
15 Dec 23
UPLOAD
Letter from SEC
21 Nov 23
CORRESP
Correspondence with SEC
13 Nov 23
UPLOAD
Letter from SEC
23 Oct 23
SEC STAFF
SEC staff action: Order
18 Jul 23
EFFECT
Notice of effectiveness
12 Jul 23
CORRESP
Correspondence with SEC
6 Jul 23
CORRESP
Correspondence with SEC
30 Jun 23
Ownership
SC 13D
Eureka Therapeutics, Inc.
27 Oct 23
3
Jiandong Xu
10 Oct 23
3
Marsha Roberts
10 Oct 23
3
Pei Xu
10 Oct 23
3
Cheng Liu
10 Oct 23
3
Xuejun Janelle Wu
10 Oct 23
3
Fan Wu
10 Oct 23
3
Initial statement of insider ownership
10 Oct 23
4
JEFFREY A ALTMAN
5 Oct 23
4
Change in insider ownership
2 Oct 23